TRENDS AND ALTERNATIVES IN TREATMENT OF MALIGNANT TUMORS OF EXTRAHEPATIC BILE DUCTS.
Stoyanov V, Dimitrova V.
Khirurgiia (Sofiia). 2015;81(3):149-60.
[Cholangiocarcinomas].
Schöning W, Haber PK, Pratschke J.
Chirurgie (Heidelb). 2025 Jan;96(1):77-86. doi: 10.1007/s00104-024-02200-z. Epub 2024 Dec 10.
Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology.
Mocchegiani F, Vincenzi P, Conte G, Nicolini D, Rossi R, Cacciaguerra AB, Vivarelli M.
World J Gastroenterol. 2023 Oct 14;29(38):5361-5373. doi: 10.3748/wjg.v29.i38.5361.
[Endosonography in tumors of the pancreas and bile ducts].
Nattermann C, Dancygier H.
Leber Magen Darm. 1993 Jan;23(1):13-8, 21-3.
[Cholangiocarcinoma].
Burgos San Juan L.
Rev Med Chil. 2008 Feb;136(2):240-8. Epub 2008 May 7.
Contrast-enhanced ultrasound examination of the gallbladder and bile ducts: A pictorial essay.
Cokkinos DD, Antypa EG, Tsolaki S, Skylakaki M, Skoura A, Mellou V, Kalogeropoulos I.
J Clin Ultrasound. 2018 Jan;46(1):48-61. doi: 10.1002/jcu.22537. Epub 2017 Oct 6.
Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors.
Liu Q, Zhang P, Li Q.
Discov Med. 2024 Jan;36(180):48-60. doi: 10.24976/Discov.Med.202436180.4.
Current controversies in cholangiocarcinoma.
Hoyos S, Navas MC, Restrepo JC, Botero RC.
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1461-1467. doi: 10.1016/j.bbadis.2017.07.027. Epub 2017 Jul 26.
Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
Lin MX, Ye JY, Tian WS, Xu M, Zhuang BW, Lu MD, Xie XY, Kuang M.
Dig Dis Sci. 2017 Apr;62(4):1086-1094. doi: 10.1007/s10620-016-4312-1. Epub 2017 Feb 15.
Epigenome dysregulation in cholangiocarcinoma.
O'Rourke CJ, Munoz-Garrido P, Aguayo EL, Andersen JB.
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1423-1434. doi: 10.1016/j.bbadis.2017.06.014. Epub 2017 Jun 20.
